This analysis examines the market position and future outlook for Millennium. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis and assessment of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
Reasons to Purchase:
- Predict the success of Millennium's transformation from 'emerging' biotech to 'leading' biotech player
- Benchmark Millennium's performance against key rivals in the biotechnology sector
